Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier P Gisbert

Showing results (341-350 of 668) with videos related to

Pageof 67
Sort By:
International Journal of Clinical Practice|September 5, 2017
Fourteen-day high-dose esomeprazole, amoxicillin and metronidazole as third-line treatment for Helicobacter pylori infectionIgnasi Puig, Jesús M González-Santiago, Javier Molina-Infante, et al.
Journal of Hepatology|October 29, 2021
Hallmarks of the human intestinal microbiome on liver maturation and functionJoana I Almeida, Miguel F Tenreiro, Lucía Martinez-Santamaria, et al.
Expert Opinion on Biological Therapy|April 11, 2023
Real-world observational cohort study of treatment patterns and safety outcomes of infliximab biosimilar CT-P13 for the treatment of inflammatory bowel disease (CONNECT-IBD)Bernd Bokemeyer, Tibor Hlavaty, Matthieu Allez, et al.
Inflammatory Bowel Diseases|August 10, 2024
Benefit-Risk Trade-offs and Patient Preferences for Therapy Selection in Ulcerative Colitis: a Multicountry Preference StudyJavier P Gisbert, Stefan Schreiber, Corey A Siegel, et al.
Gastroenterologia Y Hepatologia|January 18, 2020
Survey of adherence to treatment in inflammatory bowel disease. ENADEII studyInmaculada Alonso-Abreu, Onofre Alarcón-Fernández, Marta Carrillo-Palau, et al.
Gastroenterologia Y Hepatologia|November 6, 2007
Analysis of soluble angiogenic factors in Crohn's disease: a preliminary studyInés Dueñas Pousa, José Maté Jiménez, Xamila Salcedo Mora, et al.
International Journal of Oncology|April 6, 2006
Thymidylate synthase expression pattern, expression level and single nucleotide polymorphism are predictors for disease-free survival in patients of colorectal cancer treated with 5-fluorouracilMaría-Encarnación Fernández-Contreras, Sandra Sánchez-Prudencio, José-Javier Sánchez-Hernández, et al.
Gastroenterologia Y Hepatologia|December 2, 2015
Outcome after a dose "de-intensification" strategy with anti-TNF drugs in patients with Crohn's diseaseMaría Chaparro, Manuel Barreiro-de Acosta, Esther García-Planella, et al.
Therapeutic Advances in Gastroenterology|February 16, 2026
GETECCU: a comprehensive national strategy for excellence in inflammatory bowel diseaseYamile Zabana, Ana Gutiérrez, Manuel Barreiro-de Acosta, et al.
Inflammatory Bowel Diseases|June 18, 2020
Profiling of Human Circulating Dendritic Cells and Monocyte Subsets Discriminates Between Type and Mucosal Status in Patients With Inflammatory Bowel DiseaseLorena Ortega Moreno, Samuel Fernández-Tomé, María Chaparro, et al.
Pageof 67

Showing results (341-350 of 668) with videos related to

Sort By:
Pageof 67
International Journal of Clinical Practice|September 5, 2017
Fourteen-day high-dose esomeprazole, amoxicillin and metronidazole as third-line treatment for Helicobacter pylori infectionIgnasi Puig, Jesús M González-Santiago, Javier Molina-Infante, et al.
Journal of Hepatology|October 29, 2021
Hallmarks of the human intestinal microbiome on liver maturation and functionJoana I Almeida, Miguel F Tenreiro, Lucía Martinez-Santamaria, et al.
Expert Opinion on Biological Therapy|April 11, 2023
Real-world observational cohort study of treatment patterns and safety outcomes of infliximab biosimilar CT-P13 for the treatment of inflammatory bowel disease (CONNECT-IBD)Bernd Bokemeyer, Tibor Hlavaty, Matthieu Allez, et al.
Inflammatory Bowel Diseases|August 10, 2024
Benefit-Risk Trade-offs and Patient Preferences for Therapy Selection in Ulcerative Colitis: a Multicountry Preference StudyJavier P Gisbert, Stefan Schreiber, Corey A Siegel, et al.
Gastroenterologia Y Hepatologia|January 18, 2020
Survey of adherence to treatment in inflammatory bowel disease. ENADEII studyInmaculada Alonso-Abreu, Onofre Alarcón-Fernández, Marta Carrillo-Palau, et al.
Gastroenterologia Y Hepatologia|November 6, 2007
Analysis of soluble angiogenic factors in Crohn's disease: a preliminary studyInés Dueñas Pousa, José Maté Jiménez, Xamila Salcedo Mora, et al.
International Journal of Oncology|April 6, 2006
Thymidylate synthase expression pattern, expression level and single nucleotide polymorphism are predictors for disease-free survival in patients of colorectal cancer treated with 5-fluorouracilMaría-Encarnación Fernández-Contreras, Sandra Sánchez-Prudencio, José-Javier Sánchez-Hernández, et al.
Gastroenterologia Y Hepatologia|December 2, 2015
Outcome after a dose "de-intensification" strategy with anti-TNF drugs in patients with Crohn's diseaseMaría Chaparro, Manuel Barreiro-de Acosta, Esther García-Planella, et al.
Therapeutic Advances in Gastroenterology|February 16, 2026
GETECCU: a comprehensive national strategy for excellence in inflammatory bowel diseaseYamile Zabana, Ana Gutiérrez, Manuel Barreiro-de Acosta, et al.
Inflammatory Bowel Diseases|June 18, 2020
Profiling of Human Circulating Dendritic Cells and Monocyte Subsets Discriminates Between Type and Mucosal Status in Patients With Inflammatory Bowel DiseaseLorena Ortega Moreno, Samuel Fernández-Tomé, María Chaparro, et al.
Pageof 67